Cargando…
Personalized medicine of non-gene-specific chemotherapies for non-small cell lung cancer
Non-small cell lung cancer is recognized as the deadliest cancer across the globe. In some areas, it is more common in women than even breast and cervical cancer. Its rise, vaulted by smoking habits and increasing air pollution, has garnered much attention and resource in the medical field. The firs...
Autores principales: | Jiang, Wenxiao, Cai, Guiqing, Hu, Peter, Wang, Yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642451/ https://www.ncbi.nlm.nih.gov/pubmed/34900526 http://dx.doi.org/10.1016/j.apsb.2021.02.003 |
Ejemplares similares
-
Personalized medicine in non-small cell lung cancer: a review from a pharmacogenomics perspective
por: Jiang, Wenxiao, et al.
Publicado: (2018) -
Chemotherapy of non-small cell lung cancer.
por: Williams, C. J.
Publicado: (1989) -
Personalized medicine and treatment approaches in non-small-cell lung carcinoma
por: Vadakara, Joseph, et al.
Publicado: (2012) -
Chemotherapy for Lung Cancer in the Era of Personalized Medicine
por: Lee, Seung Hyeun
Publicado: (2019) -
Antiangiogenesis for Advanced Non-Small-Cell Lung Cancer in the Era of Immunotherapy and Personalized Medicine
por: Tabchi, Samer, et al.
Publicado: (2017)